AcquisitionOther
LIGAND PHARMACEUTICALS INC acquired APEIRON Biologics AG
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
LIGAND PHARMACEUTICALS INC -> APEIRON Biologics AG · $100 Million
“The addition of QARZIBA to our commercial royalty portfolio further supports our growth strategy to invest in high-value medicines that deliver significant clinical value and generate predictable and long-term revenue streams for our investors,” said Todd Dav
Open source record (SEC) ↗